Selected research
Market Analysis & Forecast
Global Home Gut Microbiome Testing Market Analysis and Forecast 2026-2032
Market perspective
The global Home Gut Microbiome Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Home Gut Microbiome Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Home Gut Microbiome Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Home Gut Microbiome Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Home Gut Microbiome Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Home Gut Microbiome Testing include Microba, i-screen, ZOE, Cerascreen, NutriPATH, Blue Horizon, Floré, Verisana and Viome, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Home Gut Microbiome Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Home Gut Microbiome Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Home Gut Microbiome Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Home Gut Microbiome Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Home Gut Microbiome Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Home Gut Microbiome Testing revenue, projected growth trends, production technology, application and end-user industry.
Home Gut Microbiome Testing Segment by Company
Microba
i-screen
ZOE
Cerascreen
NutriPATH
Blue Horizon
Floré
Verisana
Viome
EasyDNA
AffinityDNA
Home Gut Microbiome Testing Segment by Type
DNA Test
Culturing Test
Home Gut Microbiome Testing Segment by Application
Child
Aldult
Home Gut Microbiome Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Gut Microbiome Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Home Gut Microbiome Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Gut Microbiome Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Home Gut Microbiome Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Home Gut Microbiome Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Home Gut Microbiome Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Test
- Culturing Test
Applications
- Child
- Aldult
Companies covered
- Microba
- i-screen
- ZOE
- Cerascreen
- NutriPATH
- Blue Horizon
- Floré
- Verisana
- Viome
- EasyDNA
- AffinityDNA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Home Gut Microbiome Testing Market by Type
- 1.2.1 Global Home Gut Microbiome Testing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 DNA Test
- 1.2.3 Culturing Test
- 1.3 Home Gut Microbiome Testing Market by Application
- 1.3.1 Global Home Gut Microbiome Testing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Child
- 1.3.3 Aldult
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Home Gut Microbiome Testing Market Dynamics
- 2.1 Home Gut Microbiome Testing Industry Trends
- 2.2 Home Gut Microbiome Testing Industry Drivers
- 2.3 Home Gut Microbiome Testing Industry Opportunities and Challenges
- 2.4 Home Gut Microbiome Testing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Home Gut Microbiome Testing Market Perspective (2021-2032)
- 3.2 Global Home Gut Microbiome Testing Growth Trends by Region
- 3.2.1 Global Home Gut Microbiome Testing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Home Gut Microbiome Testing Market Size by Region (2021-2026)
- 3.2.3 Global Home Gut Microbiome Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Home Gut Microbiome Testing Revenue by Players
- 4.1.1 Global Home Gut Microbiome Testing Revenue by Players (2021-2026)
- 4.1.2 Global Home Gut Microbiome Testing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Home Gut Microbiome Testing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Home Gut Microbiome Testing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Home Gut Microbiome Testing Key Players Headquarters & Area Served
- 4.4 Global Home Gut Microbiome Testing Players, Product Type & Application
- 4.5 Global Home Gut Microbiome Testing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Home Gut Microbiome Testing Market CR5 and HHI
- 4.6.3 2025 Home Gut Microbiome Testing Tier 1, Tier 2, and Tier 3
5 Home Gut Microbiome Testing Market Size by Type
- 5.1 Global Home Gut Microbiome Testing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Home Gut Microbiome Testing Revenue by Type (2021-2032)
- 5.3 Global Home Gut Microbiome Testing Revenue Market Share by Type (2021-2032)
6 Home Gut Microbiome Testing Market Size by Application
- 6.1 Global Home Gut Microbiome Testing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Home Gut Microbiome Testing Revenue by Application (2021-2032)
- 6.3 Global Home Gut Microbiome Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Microba
- 7.1.1 Microba Company Information
- 7.1.2 Microba Business Overview
- 7.1.3 Microba Home Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.1.4 Microba Home Gut Microbiome Testing Product Portfolio
- 7.1.5 Microba Recent Developments
- 7.2 i-screen
- 7.2.1 i-screen Company Information
- 7.2.2 i-screen Business Overview
- 7.2.3 i-screen Home Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.2.4 i-screen Home Gut Microbiome Testing Product Portfolio
- 7.2.5 i-screen Recent Developments
- 7.3 ZOE
- 7.3.1 ZOE Company Information
- 7.3.2 ZOE Business Overview
- 7.3.3 ZOE Home Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.3.4 ZOE Home Gut Microbiome Testing Product Portfolio
- 7.3.5 ZOE Recent Developments
- 7.4 Cerascreen
- 7.4.1 Cerascreen Company Information
- 7.4.2 Cerascreen Business Overview
- 7.4.3 Cerascreen Home Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.4.4 Cerascreen Home Gut Microbiome Testing Product Portfolio
- 7.4.5 Cerascreen Recent Developments
- 7.5 NutriPATH
- 7.5.1 NutriPATH Company Information
- 7.5.2 NutriPATH Business Overview
- 7.5.3 NutriPATH Home Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.5.4 NutriPATH Home Gut Microbiome Testing Product Portfolio
- 7.5.5 NutriPATH Recent Developments
- 7.6 Blue Horizon
- 7.6.1 Blue Horizon Company Information
- 7.6.2 Blue Horizon Business Overview
- 7.6.3 Blue Horizon Home Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.6.4 Blue Horizon Home Gut Microbiome Testing Product Portfolio
- 7.6.5 Blue Horizon Recent Developments
- 7.7 Floré
- 7.7.1 Floré Company Information
- 7.7.2 Floré Business Overview
- 7.7.3 Floré Home Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.7.4 Floré Home Gut Microbiome Testing Product Portfolio
- 7.7.5 Floré Recent Developments
- 7.8 Verisana
- 7.8.1 Verisana Company Information
- 7.8.2 Verisana Business Overview
- 7.8.3 Verisana Home Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.8.4 Verisana Home Gut Microbiome Testing Product Portfolio
- 7.8.5 Verisana Recent Developments
- 7.9 Viome
- 7.9.1 Viome Company Information
- 7.9.2 Viome Business Overview
- 7.9.3 Viome Home Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.9.4 Viome Home Gut Microbiome Testing Product Portfolio
- 7.9.5 Viome Recent Developments
- 7.10 EasyDNA
- 7.10.1 EasyDNA Company Information
- 7.10.2 EasyDNA Business Overview
- 7.10.3 EasyDNA Home Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.10.4 EasyDNA Home Gut Microbiome Testing Product Portfolio
- 7.10.5 EasyDNA Recent Developments
- 7.11 AffinityDNA
- 7.11.1 AffinityDNA Company Information
- 7.11.2 AffinityDNA Business Overview
- 7.11.3 AffinityDNA Home Gut Microbiome Testing Revenue and Gross Margin (2021-2026)
- 7.11.4 AffinityDNA Home Gut Microbiome Testing Product Portfolio
- 7.11.5 AffinityDNA Recent Developments
8 North America
- 8.1 North America Home Gut Microbiome Testing Revenue (2021-2032)
- 8.2 North America Home Gut Microbiome Testing Revenue by Type (2021-2032)
- 8.2.1 North America Home Gut Microbiome Testing Revenue by Type (2021-2026)
- 8.2.2 North America Home Gut Microbiome Testing Revenue by Type (2027-2032)
- 8.3 North America Home Gut Microbiome Testing Revenue Share by Type (2021-2032)
- 8.4 North America Home Gut Microbiome Testing Revenue by Application (2021-2032)
- 8.4.1 North America Home Gut Microbiome Testing Revenue by Application (2021-2026)
- 8.4.2 North America Home Gut Microbiome Testing Revenue by Application (2027-2032)
- 8.5 North America Home Gut Microbiome Testing Revenue Share by Application (2021-2032)
- 8.6 North America Home Gut Microbiome Testing Revenue by Country
- 8.6.1 North America Home Gut Microbiome Testing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Home Gut Microbiome Testing Revenue by Country (2021-2026)
- 8.6.3 North America Home Gut Microbiome Testing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Home Gut Microbiome Testing Revenue (2021-2032)
- 9.2 Europe Home Gut Microbiome Testing Revenue by Type (2021-2032)
- 9.2.1 Europe Home Gut Microbiome Testing Revenue by Type (2021-2026)
- 9.2.2 Europe Home Gut Microbiome Testing Revenue by Type (2027-2032)
- 9.3 Europe Home Gut Microbiome Testing Revenue Share by Type (2021-2032)
- 9.4 Europe Home Gut Microbiome Testing Revenue by Application (2021-2032)
- 9.4.1 Europe Home Gut Microbiome Testing Revenue by Application (2021-2026)
- 9.4.2 Europe Home Gut Microbiome Testing Revenue by Application (2027-2032)
- 9.5 Europe Home Gut Microbiome Testing Revenue Share by Application (2021-2032)
- 9.6 Europe Home Gut Microbiome Testing Revenue by Country
- 9.6.1 Europe Home Gut Microbiome Testing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Home Gut Microbiome Testing Revenue by Country (2021-2026)
- 9.6.3 Europe Home Gut Microbiome Testing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Home Gut Microbiome Testing Revenue (2021-2032)
- 10.2 China Home Gut Microbiome Testing Revenue by Type (2021-2032)
- 10.2.1 China Home Gut Microbiome Testing Revenue by Type (2021-2026)
- 10.2.2 China Home Gut Microbiome Testing Revenue by Type (2027-2032)
- 10.3 China Home Gut Microbiome Testing Revenue Share by Type (2021-2032)
- 10.4 China Home Gut Microbiome Testing Revenue by Application (2021-2032)
- 10.4.1 China Home Gut Microbiome Testing Revenue by Application (2021-2026)
- 10.4.2 China Home Gut Microbiome Testing Revenue by Application (2027-2032)
- 10.5 China Home Gut Microbiome Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Home Gut Microbiome Testing Revenue (2021-2032)
- 11.2 Asia Home Gut Microbiome Testing Revenue by Type (2021-2032)
- 11.2.1 Asia Home Gut Microbiome Testing Revenue by Type (2021-2026)
- 11.2.2 Asia Home Gut Microbiome Testing Revenue by Type (2027-2032)
- 11.3 Asia Home Gut Microbiome Testing Revenue Share by Type (2021-2032)
- 11.4 Asia Home Gut Microbiome Testing Revenue by Application (2021-2032)
- 11.4.1 Asia Home Gut Microbiome Testing Revenue by Application (2021-2026)
- 11.4.2 Asia Home Gut Microbiome Testing Revenue by Application (2027-2032)
- 11.5 Asia Home Gut Microbiome Testing Revenue Share by Application (2021-2032)
- 11.6 Asia Home Gut Microbiome Testing Revenue by Country
- 11.6.1 Asia Home Gut Microbiome Testing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Home Gut Microbiome Testing Revenue by Country (2021-2026)
- 11.6.3 Asia Home Gut Microbiome Testing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Home Gut Microbiome Testing Revenue (2021-2032)
- 12.2 SAMEA Home Gut Microbiome Testing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Home Gut Microbiome Testing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Home Gut Microbiome Testing Revenue by Type (2027-2032)
- 12.3 SAMEA Home Gut Microbiome Testing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Home Gut Microbiome Testing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Home Gut Microbiome Testing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Home Gut Microbiome Testing Revenue by Application (2027-2032)
- 12.5 SAMEA Home Gut Microbiome Testing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Home Gut Microbiome Testing Revenue by Country
- 12.6.1 SAMEA Home Gut Microbiome Testing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Home Gut Microbiome Testing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Home Gut Microbiome Testing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst